Medifast, Inc.

MEDNYSEConsumer Cyclical● Active

$12.07

$-0.03(-0.25%)

Market Cap$134207537

P/E Ratio—

52W High$15.46

52W Low$9.22

Avg Volume236K

Open$12.09

Beta0.66

Insider Trades Ownership Employees

Medifast, Inc. (MED) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · MED · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Medifast, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

MED insider buying and selling by quarter

MED insider selling · MED insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

157K78K0

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · MED ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

MED executive sell shares · MED board member insider trading · MED insider trading SEC filing

Showing 83 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 26, 2026	Rose Jeffrey Matthew Director	Award	6,739	—	—	18,419	Form 4
May 26, 2026	Rose Jeffrey Matthew Director	Award	11,680	—	—	11,680	Form 4
May 26, 2026	Kiai Parsa Director	Award	7,637	—	—	19,317	Form 4
May 26, 2026	Kiai Parsa Director	Award	11,680	—	—	11,680	Form 4
May 26, 2026	Thomas Andrea B Director	Award	11,680	—	—	35,697.123	Form 4
May 26, 2026	SCHLACKMAN SCOTT Director	Award	11,680	—	—	42,228.707	Form 4
May 26, 2026	Geary Elizabeth A. Director	Award	11,680	—	—	31,225	Form 4
May 11, 2026	SCHLACKMAN SCOTT Director	Purchase	2,500	$12.53	$31K	30,548.707	Form 4
May 8, 2026	SCHLACKMAN SCOTT Director	Purchase	2,500	$12.65	$32K	28,048.707	Form 4
Mar 25, 2026	MacKenzie Jonathan Barrett VP, Finance & CAO	Award	10,830	—	—	20,838	Form 4
Mar 13, 2026	MacKenzie Jonathan Barrett VP, Finance & CAO	Other	198	$9.62	$2K	10,940	Form 4
Mar 17, 2026	MacKenzie Jonathan Barrett VP, Finance & CAO	Other	70	$10.05	$704	10,870	Form 4
Mar 25, 2026	MacKenzie Jonathan Barrett VP, Finance & CAO	Other	862	$9.59	$8K	10,008	Form 4
Mar 25, 2026	Maloney James P. CFO	Award	1,014	—	—	73,033	Form 4
Mar 25, 2026	Maloney James P. CFO	Award	34,344	—	—	72,019	Form 4
Mar 13, 2026	Maloney James P. CFO	Other	918	$9.62	$9K	41,381	Form 4
Mar 17, 2026	Maloney James P. CFO	Other	482	$10.05	$5K	40,899	Form 4
Mar 25, 2026	Maloney James P. CFO	Other	3,224	$9.59	$31K	37,675	Form 4
Mar 25, 2026	Chard Daniel R Chairman & CEO · Director	Award	4,827	—	—	188,233	Form 4
Mar 25, 2026	Chard Daniel R Chairman & CEO · Director	Award	36,968	—	—	183,406	Form 4
Mar 13, 2026	Chard Daniel R Chairman & CEO · Director	Other	7,075	$9.62	$68K	169,171	Form 4
Mar 17, 2026	Chard Daniel R Chairman & CEO · Director	Other	2,638	$10.05	$27K	166,533	Form 4
Mar 25, 2026	Chard Daniel R Chairman & CEO · Director	Other	20,095	$9.59	$193K	146,438	Form 4
Mar 20, 2026	Chard Daniel R Chairman & CEO · Director	Purchase	17,678	$10.11	$179K	17,678	Form 4
Jun 25, 2025	SCHLACKMAN SCOTT Director	Award	11,168	—	—	25,548.707	Form 4

Rose Jeffrey Matthew

Director

Award

Date

May 26

6,739

Price

—

Value

—

View Form 4 on SEC.gov

Rose Jeffrey Matthew

Director

Award

Date

May 26

11,680

Price

—

Value

—

View Form 4 on SEC.gov

Kiai Parsa

Director

Award

Date

May 26

7,637

Price

—

Value

—

View Form 4 on SEC.gov

Kiai Parsa

Director

Award

Date

May 26

11,680

Price

—

Value

—

View Form 4 on SEC.gov

Thomas Andrea B

Director

Award

Date

May 26

11,680

Price

—

Value

—

View Form 4 on SEC.gov

SCHLACKMAN SCOTT

Director

Award

Date

May 26

11,680

Price

—

Value

—

View Form 4 on SEC.gov

Geary Elizabeth A.

Director

Award

Date

May 26

11,680

Price

—

Value

—

View Form 4 on SEC.gov

SCHLACKMAN SCOTT

Director

Purchase

Date

May 11

2,500

Price

$12.53

Value

$31K

View Form 4 on SEC.gov

SCHLACKMAN SCOTT

Director

Purchase

Date

May 8

2,500

Price

$12.65

Value

$32K

View Form 4 on SEC.gov

MacKenzie Jonathan Barrett

VP, Finance & CAO

Award

Date

Mar 25

10,830

Price

—

Value

—

View Form 4 on SEC.gov

MacKenzie Jonathan Barrett

VP, Finance & CAO

Other

Date

Mar 13

198

Price

$9.62

Value

$2K

View Form 4 on SEC.gov

MacKenzie Jonathan Barrett

VP, Finance & CAO

Other

Date

Mar 17

Price

$10.05

Value

$704

View Form 4 on SEC.gov

MacKenzie Jonathan Barrett

VP, Finance & CAO

Other

Date

Mar 25

862

Price

$9.59

Value

$8K

View Form 4 on SEC.gov

Maloney James P.

CFO

Award

Date

Mar 25

1,014

Price

—

Value

—

View Form 4 on SEC.gov

Maloney James P.

CFO

Award

Date

Mar 25

34,344

Price

—

Value

—

View Form 4 on SEC.gov

Maloney James P.

CFO

Other

Date

Mar 13

918

Price

$9.62

Value

$9K

View Form 4 on SEC.gov

Maloney James P.

CFO

Other

Date

Mar 17

482

Price

$10.05

Value

$5K

View Form 4 on SEC.gov

Maloney James P.

CFO

Other

Date

Mar 25

3,224

Price

$9.59

Value

$31K

View Form 4 on SEC.gov

Chard Daniel R

Chairman & CEO · Director

Award

Date

Mar 25

4,827

Price

—

Value

—

View Form 4 on SEC.gov

Chard Daniel R

Chairman & CEO · Director

Award

Date

Mar 25

36,968

Price

—

Value

—

View Form 4 on SEC.gov

Chard Daniel R

Chairman & CEO · Director

Other

Date

Mar 13

7,075

Price

$9.62

Value

$68K

View Form 4 on SEC.gov

Chard Daniel R

Chairman & CEO · Director

Other

Date

Mar 17

2,638

Price

$10.05

Value

$27K

View Form 4 on SEC.gov

Chard Daniel R

Chairman & CEO · Director

Other

Date

Mar 25

20,095

Price

$9.59

Value

$193K

View Form 4 on SEC.gov

Chard Daniel R

Chairman & CEO · Director

Purchase

Date

Mar 20

17,678

Price

$10.11

Value

$179K

View Form 4 on SEC.gov

SCHLACKMAN SCOTT

Director

Award

Date

Jun 25

11,168

Price

—

Value

—

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About MED insider trading

MED insider trades

Medifast, Inc. (MED) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Chard Daniel R (Chairman & CEO · Director), Maloney James P. (CFO), SCHLACKMAN SCOTT (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. MED insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Medifast, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

MED insider trading · 5 questions

The insiders of Medifast, Inc. (MED) include executives and directors such as Chard Daniel R (Chairman & CEO · Director), Maloney James P. (CFO), SCHLACKMAN SCOTT (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

MED board member insider tradingwho are MED insidersMED insider rosterMedifast, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026